You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the POTASSIUM PHOSPHATES (potassium phosphate, dibasic; potassium phosphate, monobasic) Drug Profile, 2024 PDF Report in the Report Store ~

POTASSIUM PHOSPHATES Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Potassium Phosphates patents expire, and when can generic versions of Potassium Phosphates launch?

Potassium Phosphates is a drug marketed by Am Regent, Amneal, Cmp Dev Llc, Fresenius Kabi Usa, and Somerset Theraps Llc. and is included in six NDAs. There is one patent protecting this drug.

This drug has one patent family member in one country.

The generic ingredient in POTASSIUM PHOSPHATES is potassium phosphate, dibasic; potassium phosphate, monobasic. There are two hundred and forty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the potassium phosphate, dibasic; potassium phosphate, monobasic profile page.

DrugPatentWatch® Generic Entry Outlook for Potassium Phosphates

Indicators of Generic Entry

< Available with Subscription >

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM PHOSPHATES?
  • What are the global sales for POTASSIUM PHOSPHATES?
  • What is Average Wholesale Price for POTASSIUM PHOSPHATES?
Summary for POTASSIUM PHOSPHATES
International Patents:1
US Patents:1
Applicants:5
NDAs:6
Finished Product Suppliers / Packagers: 5
Clinical Trials: 1
What excipients (inactive ingredients) are in POTASSIUM PHOSPHATES?POTASSIUM PHOSPHATES excipients list
DailyMed Link:POTASSIUM PHOSPHATES at DailyMed
Drug patent expirations by year for POTASSIUM PHOSPHATES
Recent Clinical Trials for POTASSIUM PHOSPHATES

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mahidol UniversityN/A

See all POTASSIUM PHOSPHATES clinical trials

Pharmacology for POTASSIUM PHOSPHATES

US Patents and Regulatory Information for POTASSIUM PHOSPHATES

POTASSIUM PHOSPHATES is protected by one US patents and two FDA Regulatory Exclusivities.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274-001 Oct 2, 2023 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Cmp Dev Llc POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 212121-001 Sep 19, 2019 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Amneal POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216344-001 Oct 10, 2023 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for POTASSIUM PHOSPHATES

See the table below for patents covering POTASSIUM PHOSPHATES around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2020081118 ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for POTASSIUM PHOSPHATES

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1441735 SPC/GB08/020 United Kingdom ⤷  Subscribe PRODUCT NAME: RALTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; REGISTERED: UK EU/1/07/436/001 20080102
1499331 13C0055 France ⤷  Subscribe PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220
0253310 SPC/GB95/010 United Kingdom ⤷  Subscribe PRODUCT NAME: 2-N-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL) METHYL) -5-(HYDROXYMETHYL) IMIDAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT; REGISTERED: SE 12209 19940902; UK 0025/0324 19941215; UK 0025/0336 19941215
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

POTASSIUM PHOSPHATES Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Potassium Phosphates

Introduction to Potassium Phosphates

Potassium phosphates, including injectable potassium phosphate and other forms like mono potassium phosphate (MKP), are crucial in various medical, agricultural, and industrial applications. Understanding the market dynamics and financial trajectory of these compounds is essential for stakeholders, including healthcare providers, pharmaceutical companies, and agricultural sectors.

Market Size and Growth Projections

Injectable Potassium Phosphate

The global market for injectable potassium phosphate is experiencing significant growth. In 2024, the market is estimated to be worth USD 562.6 million, with projections to reach USD 1,148.7 million by 2034. This growth is driven by a Compound Annual Growth Rate (CAGR) of 8.1% over the forecast period[1].

Mono Potassium Phosphate (MKP)

The MKP market, valued at USD 627.33 million in 2023, is expected to grow to USD 716.31 million by 2031, with a CAGR of 2% from 2024 to 2031. This growth is fueled by increasing demand in the food, pharmaceutical, and agricultural sectors[2].

Drivers of Market Growth

Increasing Chronic Diseases

The rise in chronic diseases such as diabetes, cardiovascular disorders, and renal conditions is a significant driver for the injectable potassium phosphate market. These conditions require effective electrolyte management, which injectable potassium phosphate provides[1].

Technological Advancements

Advances in drug formulation and delivery technologies have enhanced the efficacy and safety of injectable potassium phosphate products. This innovation is a key factor in the market's growth[1].

Agricultural Demand

For MKP, the expanding agricultural industry and the need for effective fertilizers to increase crop yields are major drivers. Additionally, the use of MKP in food processing as a nutrient enhancer and pH regulator contributes to its growing demand[2].

Government Policies and Subsidies

Government policies and subsidies, particularly in developing countries, promote the use of phosphatic fertilizers like MKP. These subsidies make fertilizers more affordable for farmers, driving higher consumption and market growth[4].

Market Segments and Applications

Injectable Potassium Phosphate

  • Healthcare Sector: The primary application is in hospitals and specialized clinics for managing electrolyte imbalances in patients with chronic diseases.
  • Geographical Markets: The USA market is a significant segment, driven by a high incidence of chronic diseases and a well-developed healthcare system[1].

Mono Potassium Phosphate (MKP)

  • Type: Available in powder, crystal, and liquid forms.
  • Applications: Used in the food and beverage industry, pharmaceuticals, animal feed and pet food, personal care and cosmetics, and as fertilizers in agriculture[2].

Financial Trajectory

Revenue Growth

The injectable potassium phosphate market is expected to more than double from USD 562.6 million in 2024 to USD 1,148.7 million by 2034, indicating a robust financial trajectory. The historical CAGR from 2019 to 2023 was 7.4%, and this trend is expected to continue with an 8.1% CAGR from 2024 to 2034[1].

Market Value Projections

For MKP, the market value is projected to increase from USD 627.33 million in 2023 to USD 716.31 million by 2031, reflecting a steady but slower growth rate compared to injectable potassium phosphate[2].

Challenges and Opportunities

Competition and Pricing Pressure

The injectable potassium phosphate market faces competition and pricing pressure, which manufacturers must navigate carefully to sustain business growth. Balancing innovation with pricing strategies is crucial[1].

Technological Innovations

Advancements in drug delivery technologies and diagnostic methodologies offer opportunities for market growth. For MKP, technological developments in production processes are expected to provide lucrative opportunities for market players[1][2].

Regulatory and Government Support

Government policies and subsidies, especially in agricultural sectors, can significantly impact market growth. Encouraging sustainable farming practices and providing subsidies for fertilizers can drive demand for MKP and other phosphates[4].

Regional Market Dynamics

USA Market

The USA is a key market for injectable potassium phosphate, driven by a high incidence of chronic diseases and a sophisticated healthcare system. The market here is expected to grow at a CAGR of 5.3% during the forecast period[1].

Global Agricultural Markets

Developing countries such as India, China, and Brazil are expanding their agricultural sectors, leading to increased demand for phosphatic fertilizers. This expansion is driven by government subsidies and the need for higher crop yields to meet growing food demands[3][4].

Key Takeaways

  • The injectable potassium phosphate market is growing rapidly due to the rise in chronic diseases and technological advancements.
  • The MKP market is driven by agricultural and food processing demands, with a steady growth rate.
  • Government policies and subsidies play a crucial role in promoting the use of phosphatic fertilizers.
  • Technological innovations in drug delivery and production processes are key opportunities for market growth.
  • Regional markets, especially the USA and developing agricultural sectors, are significant drivers of market growth.

FAQs

Q: What is the projected market size for injectable potassium phosphate by 2034?

A: The market for injectable potassium phosphate is projected to reach USD 1,148.7 million by 2034[1].

Q: What are the primary drivers of the MKP market?

A: The primary drivers include the expanding agricultural industry, the food processing sector, and the use of MKP as a nutrient enhancer and pH regulator[2].

Q: How does government support impact the phosphate market?

A: Government policies and subsidies, especially in agricultural sectors, significantly drive market growth by making fertilizers more affordable for farmers[4].

Q: What is the CAGR for the global phosphate market from 2024 to 2034?

A: The global phosphate market is projected to grow at a CAGR of 2.9% from 2024 to 2034[3].

Q: What are the key applications of mono potassium phosphate (MKP)?

A: MKP is used in the food and beverage industry, pharmaceuticals, animal feed and pet food, personal care and cosmetics, and as fertilizers in agriculture[2].

Sources

  1. Future Market Insights: Injectable Potassium Phosphate Market: Key Industry Leaders.
  2. Market Research Intellect: Global Mono Potassium Phosphate (MKP) Market Size and Projections.
  3. Future Market Insights: Phosphates Market Size, Trend, Outlook & Forecast 2034.
  4. MarketsandMarkets: Phosphate Market, Industry Size Forecast Report.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.